10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,886,929 | -28.1% | 1,718,471 | -2.7% | 0.06% | -24.7% |
| Q2 2023 | $98,593,003 | -12.6% | 1,765,634 | -12.6% | 0.08% | -8.3% |
| Q1 2023 | $112,755,440 | +42.1% | 2,021,069 | -7.2% | 0.08% | +33.3% |
| Q4 2022 | $79,365,883 | +26.3% | 2,177,988 | -1.3% | 0.06% | +21.2% |
| Q3 2022 | $62,863,000 | -1.7% | 2,207,258 | +56.1% | 0.05% | +6.1% |
| Q2 2022 | $63,976,000 | -48.0% | 1,413,839 | -12.6% | 0.05% | -40.2% |
| Q1 2022 | $123,108,000 | -42.4% | 1,618,353 | +12.8% | 0.08% | -36.9% |
| Q4 2021 | $213,636,000 | -3.7% | 1,434,185 | -5.9% | 0.13% | -5.8% |
| Q3 2021 | $221,894,000 | -34.9% | 1,524,205 | -12.4% | 0.14% | -31.3% |
| Q2 2021 | $340,604,000 | +54.1% | 1,739,374 | +42.4% | 0.20% | +45.7% |
| Q1 2021 | $221,035,000 | +392.5% | 1,221,189 | +285.3% | 0.14% | +375.9% |
| Q4 2020 | $44,880,000 | +252.0% | 316,950 | +209.9% | 0.03% | +222.2% |
| Q3 2020 | $12,751,000 | -31.4% | 102,268 | -50.9% | 0.01% | -30.8% |
| Q2 2020 | $18,593,000 | – | 208,183 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |